Jane McGuffog has over 30 years of experience in Drug Discovery and Development. She brings extensive expertise across the pharmaceutical R&D spectrum, with roles at companies including Parke Davis, Pfizer, Millennium Pharmaceuticals and Proximagen. In her last 7 years at BenevolentAI, she led DMPK, Safety, and Modelling functions, while also managing projects through Phase I and Phase II clinical development. Her deep knowledge spans DMPK, PBPK, and Translational Science, underpinned by a strong track record of project and people leadership.

At Quotient Sciences, she heads a seasoned team of modellers dedicated to advancing drug development through the application of Physiologically Based Biopharmaceutics Modelling (PBBM) and Physiologically Based Pharmacokinetic Modelling (PBPK)

She holds a BSc (Hons) in Applied Chemistry from the University of Portsmouth.